Co-expression of c-kit and stem cell factor in primary and metastatic nasopharyngeal carcinomas and nasopharyngeal epithelium

This publication has 34 references indexed in Scilit:

• Targeting c-Kit mutations: basic science to novel therapies
  Leukemia Research, 2004
• JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells
  The EMBO Journal, 2002
• Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies
  Journal of Clinical Oncology, 2002
• Kit signaling and negative regulation of daunorubicin-induced apoptosis: role of phospholipase Cγ
  Oncogene, 2001
• Phosphatidylinositol 3 kinase contributes to the transformation of hematopoietic cells by the D816V c-Kit mutant
  Blood, 2001
• Signal transducer and activator of transcription 3 activation is required for Asp816 mutant c-Kit–mediated cytokine-independent survival and proliferation in human leukemia cells
  Blood, 2001
• Early signaling pathways activated by c-Kit in hematopoietic cells
  The International Journal of Biochemistry & Cell Biology, 1999
• MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
  Nature, 1998
• Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failure
  International Journal of Radiation Oncology*Biology*Physics, 1992
• The dominant-white spotting (W) locus of the mouse encodes the c-kit proto-oncogene
  Cell, 1988